Vaccani A - Search Results

1

Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects.

Massi P, Vaccani A, Romorini S, Parolaro D. Massi P, et al. Among authors: vaccani a. J Neuroimmunol. 2001 Jul 2;117(1-2):116-24. doi: 10.1016/s0165-5728(01)00323-x. J Neuroimmunol. 2001. PMID: 11431011

2

Cannabinoids and opioids share cAMP pathway in rat splenocytes.

Massi P, Vaccani A, Rubino T, Parolaro D. Massi P, et al. Among authors: vaccani a. J Neuroimmunol. 2003 Dec;145(1-2):46-54. doi: 10.1016/j.jneuroim.2003.09.006. J Neuroimmunol. 2003. PMID: 14644030

3

The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro.

Sacerdote P, Martucci C, Vaccani A, Bariselli F, Panerai AE, Colombo A, Parolaro D, Massi P. Sacerdote P, et al. Among authors: vaccani a. J Neuroimmunol. 2005 Feb;159(1-2):97-105. doi: 10.1016/j.jneuroim.2004.10.003. Epub 2004 Dec 1. J Neuroimmunol. 2005. PMID: 15652407

4

Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines.

Massi P, Vaccani A, Ceruti S, Colombo A, Abbracchio MP, Parolaro D. Massi P, et al. Among authors: vaccani a. J Pharmacol Exp Ther. 2004 Mar;308(3):838-45. doi: 10.1124/jpet.103.061002. Epub 2003 Nov 14. J Pharmacol Exp Ther. 2004. PMID: 14617682

5

Cannabinoids, immune system and cytokine network.

Massi P, Vaccani A, Parolaro D. Massi P, et al. Among authors: vaccani a. Curr Pharm Des. 2006;12(24):3135-46. doi: 10.2174/138161206777947425. Curr Pharm Des. 2006. PMID: 16918439 Review.

6

5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.

Massi P, Valenti M, Vaccani A, Gasperi V, Perletti G, Marras E, Fezza F, Maccarrone M, Parolaro D. Massi P, et al. Among authors: vaccani a. J Neurochem. 2008 Feb;104(4):1091-100. doi: 10.1111/j.1471-4159.2007.05073.x. Epub 2007 Nov 17. J Neurochem. 2008. PMID: 18028339 Free article.

7

Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems.

Viganò D, Rubino T, Vaccani A, Bianchessi S, Marmorato P, Castiglioni C, Parolaro D. Viganò D, et al. Among authors: vaccani a. Psychopharmacology (Berl). 2005 Nov;182(4):527-36. doi: 10.1007/s00213-005-0114-4. Epub 2005 Oct 19. Psychopharmacology (Berl). 2005. PMID: 16079992

8

The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells.

Massi P, Vaccani A, Bianchessi S, Costa B, Macchi P, Parolaro D. Massi P, et al. Among authors: vaccani a. Cell Mol Life Sci. 2006 Sep;63(17):2057-66. doi: 10.1007/s00018-006-6156-x. Cell Mol Life Sci. 2006. PMID: 16909207 Free PMC article.

9

Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain.

Viganò D, Grazia Cascio M, Rubino T, Fezza F, Vaccani A, Di Marzo V, Parolaro D. Viganò D, et al. Among authors: vaccani a. Neuropsychopharmacology. 2003 Jun;28(6):1160-7. doi: 10.1038/sj.npp.1300117. Epub 2003 Mar 12. Neuropsychopharmacology. 2003. PMID: 12637958

10

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism.

Vaccani A, Massi P, Colombo A, Rubino T, Parolaro D. Vaccani A, et al. Br J Pharmacol. 2005 Apr;144(8):1032-6. doi: 10.1038/sj.bjp.0706134. Br J Pharmacol. 2005. PMID: 15700028 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters